| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.22 | 8e-12 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.33 | 8e-10 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-09 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.28 | 9e-08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |